DISEASE NAME:
HIV Infection in Ireland
CATEGORY:
STIs
HIV Infection in Ireland
HIV is a notifiable disease in Ireland and is of major public health importance. HIV data are collected by HPSC and disseminated to a wide range of professionals and members of the public.
For useful leaflets and brochures about HIV and related health issues, please visit the NAM website
For information on where to get tested for HIV and other STIs, please see www.sexualwellbeing.ie and www.man2man.ie.
HIV in Ireland, 2023
First time HIV disagnoses | 173 (rate of 3.4 per 100,000 population) |
---|---|
Total HIV diagnoses | 911 (rate of 17.7 per 100,000 population) |


*STI/HIV services were operating at reduced capacity in 2020 and 2021 during the COVID-19 pandemic
Last updated: 21 November 2024
Information on HIV is available from sexualwellbeing.ie
Antiretroviral Therapy
- Information on Antiretroviral Therapy for people living with HIV in Ireland in English and other languages is available on sexualwellbeing.ie
HSE Position on Antiretroviral Therapy for all people living with HIV (July 2017)
01, Jul 2017
728.15 KB
Pre Exposure Prophylaxis (PrEP)
- PrEP to prevent HIV information leaflets for patients are available at sexualwellbeing.ie
- PrEP information for service providers is available at sexualwellbeing.ie
Case Definitions
Clinical criteria
Not relevant for surveillance purposes
Laboratory criteria
Adults, adolescents and children aged >= 18 months
At least one of the following three:
- Positive result of a HIV screening antibody test or a combined screening test (HIV antibody and HIV p24 antigen) confirmed by a more specific antibody test (e.g. Western blot)
- Positive result of an EIA antibody test confirmed by a positive result of a further EIA test
- Positive results on two separate specimens from at least one of the following three:
- Detection of HIV nucleic acid (HIV-RNA, HIV-DNA)
- Demonstration of HIV by HIV p24 antigen test, including neutralisation assay
- Isolation of HIV
Children aged <18 months
Positive results on two separate specimens (excluding cord blood) from at least one of the following three:
- Isolation of HIV
- Detection of HIV nucleic acid (HIV-RNA, HIV-DNA)
- Demonstration of HIV by HIV p24 antigen test, including neutralisation assay in a child >=1 month of age
Epidemiological criteria
NA
Case classification
A. Possible case
NA
B. Probable case
NA
C. Confirmed case
Any person meeting the laboratory criteria for HIV infection
Current as of: 24 January 2019
Guidance
- Guidelines for the Emergency Management of Injuries (EMI) and Post-Exposure Prophylaxis (PEP)
- HIV Treatment and PrEP - Guidance and patient information leaflets
- HIV in pregnancy guidelines, Society for the Study of Sexually Transmitted Diseases in Ireland (Feb 2012)
- HIV testing: increasing uptake and effectiveness in the European Union. ECDC (2010)